Arrowstreet Capital’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-25,580
| Closed | -$42.2K | – | 1867 |
|
|
2024
Q4 | $42.2K | Sell |
25,580
-6,518
| -20% | -$10.8K | ﹤0.01% | 1700 |
|
|
2024
Q3 | $112K | Buy |
+32,098
| New | +$112K | ﹤0.01% | 1679 |
|
|
2021
Q4 | – | Sell |
-25,100
| Closed | -$1.49M | – | 1522 |
|
|
2021
Q3 | $1.49M | Buy |
25,100
+21,300
| +561% | +$1.26M | ﹤0.01% | 1203 |
|
|
2021
Q2 | $330K | Buy |
+3,800
| New | +$330K | ﹤0.01% | 1732 |
|
|
2021
Q1 | – | Sell |
-69,636
| Closed | -$6.33M | – | 2323 |
|
|
2020
Q4 | $6.33M | Buy |
69,636
+35,477
| +104% | +$3.23M | 0.01% | 1101 |
|
|
2020
Q3 | $1.37M | Buy |
+34,159
| New | +$1.37M | ﹤0.01% | 1710 |
|
|
2020
Q1 | – | Sell |
-31,900
| Closed | -$624K | – | 1942 |
|
|
2019
Q4 | $624K | Buy |
+31,900
| New | +$624K | ﹤0.01% | 1447 |
|
|
2019
Q2 | – | Sell |
-19,300
| Closed | -$339K | – | 1480 |
|
|
2019
Q1 | $339K | Buy |
19,300
+8,530
| +79% | +$150K | ﹤0.01% | 1564 |
|
|
2018
Q4 | $138K | Buy |
+10,770
| New | +$138K | ﹤0.01% | 1283 |
|